$Wolfspeed Inc.(WOLF)$ 公司最新财报显示，其AI数据中心应用业务环比增长约30%，成为重要的结构性亮点，同时碳化硅行业需求改善趋势获得多方确认，AI电源需求增长显著。 此外，公司的基本面也出现积极变化。Wolfspeed功率器件业务中已有90%的营收来自莫霍克谷8英寸器件厂，并且公司通过战略再融资将优先担保债务缩减了约43%，资产负债状况得到显著改善。尽管财报指引仍显疲软，但市场的交易逻辑已从关注短期业绩转向聚焦AI驱动的长期增量预期，这推动了股价在夜盘走强。 $Wolfspeed Inc.(WOLF)$  

$Marvell Technology(MRVL)$ 如果你认为： • AI 数据中心未来 5–10 年仍将高速扩张 • 云厂商一定会走“自研芯片 + 降本增效”路线 • 数据中心互连和定制 ASIC 是长期趋势 那么： • MRVL 是一个极具性价比的“AI 基础设施核心成长股”

$Micron Technology(MU)$ 美光目前市盈率(PE)仅约9.9倍，而整个半导体行业的估值中位数约为32倍。与此同时，公司未来每股收益(EPS)增长预期高达327%，显示其盈利增长速度远高于行业平均水平。 受AI带动的存储芯片需求激增推动，美光股价近期持续强势。数据显示，公司股价过去12个月累计上涨约720%，近一个月涨幅也达到约80%。 $美光科技(MU)$  

$Stellantis NV(STLA)$ 汽车制造商斯泰兰蒂斯集团（Stellantis）与法国人工智能公司 Mistral AI 于周三在联合新闻稿中宣布，将扩大双方现有合作关系，以在斯泰兰蒂斯集团的各项业务运营中进一步推动人工智能应用

$Micron Technology(MU)$ A global shortage is driving prices higher, making 47-year-old Micron Technology one of the market's most active trades. The company's market capitalization surpassed $800 billion for the first time this week, with its stock soaring over 750% in the past year. CEO Sanjay Mehrotra previously stated that due to supply constraints, core customers are currently receiving only "50% to two-thirds" of their required memory chips. $美光科技(MU)$  

$Entero Therapeutics, Inc.(ENTO)$ (formerly First Wave BioPharma) is a clinical-stage biopharmaceutical company focused on developing orally delivered therapies for gastrointestinal (GI) diseases. The company’s innovative pipeline, which targets unmet needs in GI healthcare, provides several compelling reasons to consider it as an investment opportunity. Key Advantages: 1. Targeted Therapeutic Approach: Entero Therapeutics specializes in orally delivered biotherapeutics aimed at GI disorders, positioning itself in a growing market where the demand for novel treatments is increasing. Their lead drug candidates, including latiglutenase for celiac disease and adrulipase for exocrine pancreatic insufficiency, are undergoing Phase 2 trials . 2. Diver

In light of recent developments,$Standard Lithium(SLI)$ presents a compelling opportunity for investors seeking exposure to the rapidly growing electric vehicle (EV) and renewable energy sectors. On Friday, the Biden administration announced a major funding initiative aimed at boosting domestic production of critical materials for electric vehicles, with more than $3 billion allocated across 25 battery manufacturing projects in 14 states. Among the beneficiaries is SWA Lithium LLC, a joint venture between Standard Lithium and $Equinor ASA(EQNR)$, which has been awarded $225 million. This substantial grant underscores the importance of lithium as a strategic resource and positions Standard Lithium at t

Stock Recommendation:$Semler Scientific, Inc.(SMLR)$ Introduction to Semler Scientific (SMLR) Semler Scientific, Inc. (NASDAQ: SMLR) is a medical technology company focused on developing and marketing products for assessing chronic diseases. Known for its flagship product, QuantaFlo, the company has established a strong presence in the U.S. healthcare industry by providing solutions for early detection of vascular disease. SMLR’s products aim to improve patient outcomes, reduce healthcare costs, and support value-based care—a growing trend in the medical field. Market Position and Competitive Edge Semler’s niche focus on vascular disease diagnostics gives it a strong advantage in the healthcare technology sector. Unlike larger companies that may h

$SentinelOne, Inc(S)$ view order details.